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 2 
ABSTRACT 1 
 2 
The mecA gene is carried by a large (32 – 60kb) section of chromosomally 3 
inserted DNA, which upon digestion with ClaI, yields 2 fragments.  One fragment 4 
includes downstream sequences of mecA that exhibit considerable strain to strain 5 
variation in molecular size, ranging from 3.5 to 20kb.  Thus most of the 6 
polymorphisms observed in the mecA region reflect variation in DNA 7 
downstream of mecA.  We describe an approach to the rapid genotyping of 8 
methicillin-resistant Staphylococcus aureus (MRSA). It was hypothesised that 9 
assaying for the presence or absence of variable or mobile elements previously 10 
shown to be associated with the mecA region, would provide useful typing 11 
information. This was tested using  65 Australian MRSA isolates, and the results 12 
compared with pulse-field electrophoresis. These strains could be divided into 16 13 
pulsotypes, with eight closely related subtypes (A0 to A7) within type A.  In total 14 
13 different mecA associated  patterns were found.  There was good correlation 15 
between the pulsotype and the  mecA region polymorphisms for the closely 16 
related community acquired isolates but poor correlation with the more diverse 17 
health care facility acquired isolates. It was concluded that this approach may be 18 
useful for the rapid identification of epidemic clones but is less useful as a 19 
generally applicable tool for epidemiological investigations. 20 
 3 
INTRODUCTION: 1 
 2 
Staphylococcus aureus is a major pathogen that is associated with serious 3 
community-acquired and nosocomial disease (13, 44). Methicillin-resistant 4 
S.aureus (MRSA) strains rapidly emerged and became a major clinical problem 5 
within hospitals during the 1960s in Europe and the 1970s in the United States 6 
and elsewhere (16, 23, 35, 42). Outbreaks of hospital-acquired infections due to 7 
(MRSA) are being reported with increasing frequency  (3, 46, 50, 53) and most 8 
recently there has been a trend towards community acquisition of this organism 9 
(5).  In eastern Australia the appearance of MRSA was first documented as early 10 
as 1965 (40) and it has been endemic since (51,52). 11 
 12 
Traditional methods of screening for MRSA use susceptibility tests that are 13 
dependent on the phenotypic expression of resistance (4, 36).  However, these 14 
tests are time-consuming, requiring an initial culture period of 18 to 24h followed 15 
by an additional 18 to 24h period for antibiotic susceptibility testing (30).  DNA-16 
based assays for the detection of antibiotic resistance provide a rapid method for 17 
the detection of MRSA (2).  These assays test for the presence of genes that 18 
confer antibiotic resistance and thus have an inherent time advantage over culture-19 
based tests that require phenotypic expression of the genes. 20 
 21 
Molecular typing methods based on the analysis of the genetic structure of 22 
bacteria, are used to address many different problems such as the study of 23 
genomic organisation and evolution, the identification of patterns of infection, the 24 
identification of sources of transmission, the epidemiological surveillance of 25 
 4 
infectious diseases and for investigations into outbreaks. Over the last few years 1 
different molecular-based procedures have been used all over the world and 2 
guidelines and general criteria have been proposed to interpret the results obtained 3 
(43, 45,48, 49).  Examples include plasmid profiling, Southern blot analysis of 4 
chromosomal DNA, polymerase chain reaction (PCR) fingerprinting (e.g. REP-5 
PCR and  RAPD  families of methods), macrorestriction analysis and multilocus 6 
sequence typing (MLST) (14, 28). The most widely used molecular typing 7 
method for the study of the local and global epidemiologies of MRSA is pulsed-8 
field gel electrophoresis (PFGE) of large restriction fragments (1, 49).  This 9 
method has proved very successful for the investigation of nosocomial outbreaks 10 
(7, 12, 18, 38) and has also been used to identify epidemic MRSA (EMRSA) 11 
clones that have a particular ability to cause major outbreaks and to spread 12 
nationally and internationally  (9, 11, 32, 39).  However, PFGE is time consuming 13 
and is best suited to large scale epidemiological investigations rather than rapid 14 
identification procedures in the clinical or pathology laboratory environment. It 15 
would be useful to be able to rapidly identify EMRSA strains because these are 16 
frequently extant in the community as well as in health care facilities, and their 17 
identification has both public health and infection control implications.  18 
 19 
Methicillin resistance in S. aureus is mediated by the production of an altered 20 
penicillin-binding protein PBP 2a (4, 17, 24, 26, 29). The mecA gene is located 21 
within a large (32-60 kb) section of chromosomally inserted DNA, which has  no 22 
homologues in methicillin-susceptible strains (17). The polymorphic  mecA gene 23 
region has been used as an epidemiological marker and has also been the basis of 24 
studies concerning the evolutionary origin of methicillin resistance in S. aureus. 25 
 5 
MecA has a single ClaI digestion site that yields 2 mecA hybridising fragments, 1 
one of which includes downstream sequences of mecA that exhibit considerable 2 
strain to strain variation in molecular size, ranging from 3.5 to 20kb (33).  Thus 3 
most of the polymorphisms observed in the mecA region reflect variation in DNA 4 
downstream of mecA.  Until now, up to 21 such polymorphisms have been 5 
identified in various MRSA isolates (6, 11 ,22, 25, 33).   6 
 7 
We have hypothesised that the mobile elements found downstream of mecA are  a 8 
useful resource for the rapid typing of MRSA using simple and rapid gene 9 
detection procedures.  The rationale for adopting this approach is that a gene 10 
detection-based  method would be particularly suitable for automation using e.g. a 11 
microtitre-plate based PCR assay, a hybridisation array or  a real-time PCR 12 
device. We have developed such a method and compared it with PFGE using a 13 
variety of MRSA strains from South East Queensland, Australia. South East 14 
Queensland recently experienced an epidemic of gentamicin-susceptible 15 
community-acquired MRSA on a background of endemic gentamicin-resistant 16 
healthcare-acquired MRSA infection, and it was of particular interest to determine 17 
if this approach could be used to distinguish  community-acquired and healthcare-18 
acquired isolates.  19 
 20 
MATERIALS AND METHODS: 21 
 22 
Isolates: 23 
In total, 65 S. aureus isolates were included in this study.  Thirty-six of these 24 
came from Brisbane and have been previously described by Nimmo et al. (32). 25 
 6 
Twenty-eight isolates came from patients in Ipswich, 30 miles west of Brisbane.  1 
The remaining isolate is from Brisbane conforms to the description of UK 2 
EMRSA-15 by O’Neill et al., (34) in that it is resistant to erythromycin and 3 
ciprofloxacin, and has a pulsotype consistent with that strain.  Table 1 lists all the 4 
isolates used in this study, together with their mode of acquisition and patient  5 
ethnicity.  6 
 7 
Preparation of isolates for PCR: 8 
All strains were cultured overnight on tryptic soy agar plates (Oxoid).  A single 9 
colony was suspended in 100µl of sterile distilled H2O and boiled for 10 minutes.  10 
For each PCR reaction, 10µl of cell lysate was used. 11 
 12 
Identification: 13 
All isolates were identified as S. aureus by the presence of clumping factor  and 14 
the detection of the nucA gene (27).  The 50µl PCR reaction mixture consisted of 15 
10µl of cell lysate, 0.2mM of each deoxynucleoside triphosphate (Roche), 0.5µM  16 
of each primer, 1U Platinum Taq DNA polymerase (Gibco BRL, Life 17 
Technologies), 10x PCR buffer and 1.5mM MgCl2.  DNA amplification consisted 18 
of an initial cycle of 95ºC for 5 minutes, followed by 30 cycles of 95ºC for 30 19 
seconds, 50ºC for 30 seconds, 72ºC for 30 seconds with a final extension step of 20 
72ºC for 10 minutes.  PCR products were visualized on 2% agarose gels stained 21 
with ethidium bromide.  The size of the nucA gene amplicon was 270bp. 22 
mecA nucleotide sequence accession numbers: 23 
Previously published sequences  were obtained through the GenBank database 24 
website (http://www.ncbi.nlm.nih.gov).  The accession numbers are as follows: 25 
 7 
AF 142100 (mecR1 170bp deletion;  strain LHH1) 1 
AF 181950 (ClaI::mecA downstream vicinity;  strain HUC19) 2 
M 19465 (pUB 110) 3 
J 01764 (pT 181) 4 
L 29436 (pI 258) 5 
M 18086 (IS 256) 6 
 7 
PCR assays: 8 
Primers were designed to amplify fragments of mobile elements previously 9 
shown to be associated with the mecA downstream region.  The primer sequences 10 
are listed in Table 2.  DNA amplification conditions were as described for the 11 
detection of the nucA gene (above).  The sizes of the respective amplicons are 12 
also listed in Table 2.  These PCR products were visualized on 2% agarose gels 13 
stained with ethidium bromide. We have termed this procedure MAME (mec 14 
associated mobile element) typing.  15 
 16 
Control organisms: 17 
Control strains used for the nucA gene detection were S. aureus ATCC 29213 (ß-18 
lactamase positive), S. aureus ATCC 25923 and S. aureus NCTC 6571.  19 
Furthermore, S. aureus  ATCC 49476 (mecA positive) was used as a control for 20 
the amplification of the mecA downstream polymorphic region.  Several Gram-21 
negative organisms were also included as negative controls for both the nucA 22 
gene and the mecA downstream polymorphic region.  They were:  Pseudomonas 23 
aeruginosa ATCC 27853, Escherichia coli ATCC 25922, Acinetobacter 24 
baumanii ATCC 19606, Enterobacter aerogenes ATCC 13048, Klebsiella 25 
 8 
pneumoniae ATCC 13883, Proteus mirabilis ATCC 7002 and Serratia 1 
marcescens ATCC 8100. 2 
 3 
Fingerprinting by PFGE: 4 
Pulsed-field gel electrophoresis of chromosomal DNA was performed as 5 
described previously by Nimmo et al. (29). 6 
 7 
Multilocus sequence typing.  8 
 9 
Amplification primers and sequencing procedures for the seven loci were as 10 
specified by Enright et al (14). All sequencing was on both strands. The 11 
sequences obtained were compared with the sequences at the MLST web site at 12 
http://www.mlst.net/.  13 
 14 
 15 
 16 
 9 
RESULTS AND DISCUSSION 1 
 2 
Strains: 3 
Of the 65 strains tested in this study, 37 strains were community acquired, and 25 4 
strains hospital acquired (Table 1). Thirty-six  of the strains  were isolated from 5 
Caucasians and 22 strains originated from the Polynesian population.  The 6 
majority of strains isolated from Caucasians were hospital acquired (n = 23), 7 
whereas almost all of the Polynesian strains were community acquired (n = 22). 8 
 9 
Pulsed-field gel electrophoresis pulsotypes: 10 
 11 
Previously published results (31) for 31 isolates showed that nine pulsotypes (A 12 
to E, G, I, J, L) could be distinguished.   There were five closely related subtypes 13 
(A0 to A4) within type A.  All the isolates from Polynesian and Aboriginal hosts 14 
and four of the isolates from  Caucasian hosts  fell within type A. The hospital 15 
and nursing home acquired isolates had varied pulsotypes. 16 
In the second subset of isolates tested, all the Polynesian and the majority of the 17 
Causasian strains also fell into A subtypes.  However, there were a small number 18 
of  isolates that showed unique pulsotypes not found in the original set of isolates 19 
(O, P1, P2, Q, R, R1, S, S1, S2).  These pulsotypes were mostly found in isolates 20 
from  Caucasian patients.  21 
 22 
nucA gene detection: 23 
All the isolates included in this study were positive for nucA gene detection.  24 
 25 
 10 
 1 
MAME typing: 2 
Each strain was analysed by PCR for fragments of mecR1, the hypervariable 3 
region (HVR), pUB110, pI258, pT181, IS256 and the junction between the 4 
downstream common region and Ins117.  The target genes and primer positions 5 
are shown in Fig. 1. Thirteen different patterns were found (Table 3). The results 6 
were completely reproducible upon repetition.  7 
The majority of the isolates (22 in total) showed MAME pattern 1, i.e. the regions 8 
that were amplified were the hyper-variable region, Ins 117 and mecR1.  The 9 
second largest group of strains fell into polymorphic pattern 2.  The MAME types 10 
of each strain are shown in Table 1. All targets provided information (i.e. were 11 
present in some but not all strains). This was somewhat surprising in the case of 12 
mecR1 which is thought to be always present upstream of mecA (21, 37, 47, 54) 13 
and in the case of IS256 which has often been found to be present in multiple 14 
copies in the staphylococcal genome (10). A possible explanation for the absence 15 
of IS256 from some strains is that a large proportion of these strains are 16 
gentamicin sensitive and so would not be expected to possess the aminoglycoside 17 
resistance transposon Tn4001 which has IS256 at its ends and is probably a 18 
source of other IS256 copies in the genome. In the case of mecR1, it is clear that 19 
there are several polymorphisms in this region (20, 21, 33).  The forward primer 20 
was designed to anneal very close to the end point of the 170 bp deletion 21 
identified by Oliveira et al (33).  It may be that strains that did not give a product 22 
from the mecR1 specific primers possess mecR1 variants deleted for the forward 23 
primer binding site. Alternatively, the mecR1 negative strains may be similar to 24 
 11 
the deletion variant “a” described by Kobayashi et al (20 ) which entirely lacks 1 
the region encompassed by the primers. This warrants further investigation.  2 
 3 
In addition, two isolates that were initially classed as MRSA on the basis of 4 
phenotype proved to be negative for mecA and all the MAME targets. These were  5 
K722538 which was described as a gentamycin resistant MRSA by Nimmo et al 6 
(31), and IPO1M2426 which originated from a hospital acquired infection (this 7 
study). It is likely that these isolates have lost the entire mec region upon storage 8 
and/or subculture.   9 
 10 
Control strains:   11 
As can be seen in Figure 1, the mecA positive S. aureus control strain (ATCC 12 
49476) possesses the hypervariable region, pT181, pI258, mecR1 and IS256 13 
regions.  The ß-lactamase positive and both the sensitive S. aureus strains did not 14 
display any of the mecA polymorphic regions, which is to be expected.  15 
Furthermore, none of the Gram-negative control isolates tested were shown to 16 
contain any of the polymorphic regions.  17 
 18 
Correlation between PFGE and MAME 19 
 20 
 An important rationale for this study was the development of a simple approach 21 
for identifying MRSA clones associated with community acquisition in South 22 
East Queensland, Australia. The data in Table 1 show an apparent association 23 
between community isolation, an A1-5 pulsotype and MAME types 1,2 and 7. 24 
This relationship is depicted graphically in Fig. 2A.   While the correlation  is not 25 
 12 
absolute, it is quite strong with 29 strains being pulsotype A, community 1 
acquired, and MAME type 1,2 or 7. PFGE and MAME typing were similarly 2 
sensitive in their ability to detect community isolates, and the use of both methods 3 
together identified all the community isolates. Because MAME types 1,2 and 7 4 
are quite similar to each other, it would be possible in principle to identify these 5 
types using fewer targets. Within the current data-set, strains that are positive for 6 
Ins117 and negative for pUB110, pT181 and IS256 are unambiguously MAME 7 
type 1,2 or 7.  8 
 9 
The correlation between MAME typing and PFGE in a more diverse population 10 
was tested by examining the health facility acquired strains (Fig. 2B). It is evident 11 
that there are significant differences between the results from the two procedures, 12 
with instances of multiple pulsotypes in single MAME types and multiple MAME 13 
types in single pulsotypes occurring. The resolving power of the two techniques 14 
in concert clearly exceeded either technique in isolation, with virtually all health 15 
care-derived isolates possessing a unique MAME type/pulsotype combination. 16 
The only instance of good correlation between the two methods was with the 17 
three gentamicin resistant isolates which were all pulsotype F and MAME type 5. 18 
This probably reflects a very close relationship between the three isolates 19 
consistent with their acquisition by cross infection.  20 
 21 
There are two different phenomena that may contribute to the lack of correlation 22 
between the MAME types and PFGE in the more divergent health care facility 23 
isolates. Firstly, it found by Feil et al (15) that the level of recombination in 24 
natural populations of S aureus is sufficient to disrupt linkage between allele of 25 
 13 
genes located in different parts of the genome. It may be inferred from this 1 
finding that no method that interrogates a small part of the genome will be a 2 
reliable and generally applicable tool for epidemiological analyses. Secondly, it is 3 
possible that the mec locus itself undergoes frequent variation. The correlation of 4 
three different MAME types with community isolation suggests that this is a 5 
significant factor.  Studies in S. aureus and other largely  non-clonal organisms 6 
have shown that virulent or highly transmissable clones can emerge from non-7 
clonal backgrounds (8). In these instances, dissemination outruns recombination.  8 
Consequently, a method that targets only a small portion of the genome has some 9 
ability to detect such clones. The difference between the levels of correlation 10 
between PFGE and MAME typing for the closely related community acquired 11 
and more divergent health care facility acquired isolates is a clear demonstration 12 
of this.  13 
 14 
One example of MAME being able to discriminate between two strains of the 15 
same pulsotype is provided by the two pulsotype D strains . One of these is 16 
MAME type 1 (strain F829549) and the other MAME type 8 (strain C801535). In 17 
order to determine if for some reason PFGE was failing to discriminate strains 18 
that were signficantly divergent, these two strains were subject to MLST.  The 19 
results of this are shown in Table 4. The two strains were virtually identical with a 20 
single base difference present at in the tpi sequence, and no differences between 21 
the isolates at the other six loci. It was therefore concluded that these strains are 22 
very closely related but may still be discriminated by MAME typing. This 23 
suggests that variation at the mec locus does occur frequently. It was also of 24 
 14 
interest that both strains were of a novel sequence type, and that the allele at the 1 
tpi locus of isolate C801535 was previously unreported.  2 
 3 
In conclusion, we have found that information for identifying MRSA clones can 4 
be obtained by assaying for the presence or otherwise of a small number of 5 
variable or mobile stretches of DNA that are commonly found in association with 6 
the mecA gene. This may prove useful in the design of straightforward  7 
multiplexed, real time  or microplate-based PCR assays for the rapid 8 
identification of particular MRSA clones.  9 
 10 
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Figure Legends 1 
 2 
Fig. 1.  3 
 4 
Variable and mobile elements associated with mecA and the locations of the 5 
primers used in the MAME typing 6 
 7 
Fig. 2 8 
 9 
A. Association between community acquisition, pulsotype A, and MAME types 10 
1,2 and 7. The numbers represent the numbers of isolates in each category. 11 
B.  Correlation between PFGE and MAME typing for health care facility 12 
acquired isolates. Each alphanumeric code is “MAME type, pulsotype 13 
(number of isolates)”. Solid circles surround each pulsotype and dotted circles 14 
surround each MAME type. The symbol “**” represents the EMRSA-15 15 
pulsotype.  16 
 17 
 18 
 19 
 20 
  21 
 22 
 23 
 24 
Table 1:  MRSA strains, their mode of acquisition, host ethnicity, PFGE and 1 
MAME types. Starred strains have been described previously (31 ).  2 
 3 
Isolate Acquisition Ethnicity PFGE type MAME type 
*K703484 Hospital Caucasian G1 3 
*B8-31 Pathcentre  K 6 
*J710566 Nursing 
Home 
Caucasian C 6 
*A803355 Community Polynesian A0 2 
*A806533 Community Polynesian A0 2 
*A823547 Community Aboriginal A1 2 
*A830538 Community Caucasian A0 2 
*B826559 Community Polynesian A0 2 
*C801535 Hospital Caucasian D 8 
*B827549 Nursing 
Home 
Caucasian E 4 
*C810534 Community Caucasian A1 2 
*D808118 Hospital Caucasian L 4 
*D817541 Community Caucasian A0 2 
*D821522 Community Polynesian A2 2 
*D828354 Hospital Caucasian E 4 
*D828570 Community  Polynesian A0 1 
*E802537 Community Polynesian A3 1 
*E803543 Community Polynesian A0 1 
*E804531 Hospital Caucasian I 1 
*E822547 Community Polynesian A0 1 
*E822485 Hospital  Caucasian B 13 
*F810539 Community Caucasian A0 1 
*F829549 Community Caucasian D 1 
*G821561 Community Polynesian A1 1 
*G823530 Community  Polynesian A0 2 
*F809715 Community  Polynesian A0 1 
*F809718 Community  Polynesian A0 1 
*H823537 Community  Polynesian A0 2 
*I823541 Hospital Caucasian G2 3 
*I802552 Hospital Polynesian A4 2 
*I816601 Community  Polynesian A0 2 
*K705613 Hospital(GR)  Caucasian F2 5 
*K711532 Hospital (GR) Caucasian F3 5 
*K714372 Hospital (GR) Caucasian F4 5 
*E812560 Hospital Caucasian J 3 
66460/98 Community New Zealand A0 7 
67043/98 Community New Zealand A0 4 
IP00M3616 Community Polynesian A7 7 
IP00M11030 Community Polynesian A0 6 
IP00M11247 Community Polynesian A0 1 
IP00M16156 Community Polynesian A6 7 
IP00M16287 Hospital Polynesian A5 2 
IP00M17427 Community Polynesian A0 2 
IP01M2090 Community New Zealand A5 1 
 25 
66593/98 Community Caucasian A0 1 
IP00M3393 Community Caucasian A0 1 
IP00M3360 Hospital Caucasian A0 1 
IP00M15446 Community Caucasian R 1 
IP00M16759 Community Caucasian A5 1 
IP00M17753 Community Torres Strait 
Islander 
R1 1 
IP01M430 Community Caucasian R 1 
IP01M1984 Hospital Caucasian A0 1 
68284/98 Community Polynesian A5 3 
73742/99 Community New Zealand A5 1 
IP00M11998 Community Caucasian R 1 
IP00M13517 Hospital Caucasian S2 9 
IP01M1081 Hospital Caucasian Q 2 
IP01M2046 Hospital Caucasian P1 1 
IP00M14848 Hospital Caucasian S1 3 
IP01M81 Hospital Caucasian S 10 
IP00M14235 Hospital Caucasian O 3 
IP00M17006 Hospital Caucasian S 12 
PA01M18489  Hospital 
(EMRSA-15) 
Caucasian ** 11 
 1 
** The pulsotype of this isolate was essentially identical to that of the EMRSA-15 2 
described by O’Neill et al (34).3 
 26 
Table 2:  Primers used for MAME typing. 1 
 2 
GenBank 
accession 
number 
Target Primer Sequence PCR 
Amplicon 
size 
AF 181950 Hypervariable 
region 
HVRPF TGC AAC ATC TAA CTC CAA CC 300bp 
  HVRP2 TGG AGC TTG GGA CAT AAA TG  
M19465 pUB110 DF4 TAA CAT GCT GTT TTA ACC 331bp 
  MR1 TGA ACG TGG CTC TGA CCG  
AF 181950 Ins 117 MDVF1 GCT TGG GTA ACT TAT CAT GG 215bp 
  IS117R1 CTA AAT ATA GTA AAT TAC GG  
J01764 pT181 DF1 CAC GAG ATG AAA TGA TTT GG 255bp 
  DR1 GCA TCT GCA TTA TCT TTA CG  
L29436 pI258 DF2 ATA GAA AGG AAA AAA CAT GG 295bp 
  DR2 TTT ATA CGT AAA CCA GTC GG  
L29436 pI258 EF1 CAA AGT GTA AGT AAC CCG 270bp 
  ER1 TAT ACG TAA ACC AGT CGG  
AF142100 mecR1 AF1 TGA TAT GGG TAT TTG G 406bp 
  AR1 TTT TTC ACA GTC ATT GTC C  
M18086 IS256 DF3 ACT AAT GGA AAA TCA ACG 371bp 
  DR3 TTT TTT TCT GAT AAT AAA CG  
 3 
 27 
Table 3: MAME types 1 
PCR amplicons No.of 
isolates 
Hypervariable 
region 
pUB110 Ins 
117 
pT181 pI258 MecR1 IS256 
Genotype 
pattern no.
23 + - + - - + - 1 
15 + - + - - - - 2 
6 + + + - - + + 3 
4 + - + + - - - 4 
3 + - - - + + + 5 
3 + - - - - - - 6 
3 - - + - - - - 7 
1 + - - - - + - 8 
1 + + + - - - - 9 
1 - - + - - + + 10 
1 - - - - - - + 11 
1 + + + - - - + 12 
1 + + + - - + - 13 
 2 
 28 
 1 
 2 
Table 4: Multilocus sequence typing of two pulsotype D strains. The numbers are 3 
allele numbers. The sequence at the tpi locus of strain C801535 from 4 
allele 4 by a C to T change at position 110 (numbering as per the MLST 5 
web site (http://www.mlst.net/).) 6 
 7 
 
Locus 
 
F829549 
 
C801535 
arc 22 22 
aro 1 1 
glp 14 14 
gmk 23 23 
pta 12 12 
tpi 4 new 
yqi 31 31 
 8 
